Comparable Outcomes of AML Patients Receiving Haplo-HCT with Thiotepa/Busulfan/Fludarabine Conditioning and Post-Transplant Cyclophosphamide Versus a Matched Unrelated Donor with Fludarabine/Busulfan Conditioning, Regardless of Disease Status

Affiliation auteurs!!!! Error affiliation !!!!
TitreComparable Outcomes of AML Patients Receiving Haplo-HCT with Thiotepa/Busulfan/Fludarabine Conditioning and Post-Transplant Cyclophosphamide Versus a Matched Unrelated Donor with Fludarabine/Busulfan Conditioning, Regardless of Disease Status
Type de publicationJournal Article
Year of Publication2020
AuteursBazarbachi A, Labopin M, Blaise D, Forcade E, Socie G, Berceanu A, Bulabois CEric, Kroger N, Rambaldi A, Ceballos P, Mielke S, Yakoub-Agha I, Savani B, Spyridonidis A, Nagler A, Mohty M
JournalBONE MARROW TRANSPLANTATION
Volume55
Pagination23-24
Date PublishedDEC
Type of ArticleMeeting Abstract
ISSN0268-3369